To further validate their potential as diagnostic biomarkers for NSCLC, we examined their expression in the GSE32863 dataset (Fig. 5), which revealed that ABCA8, ADAMTS8, ASPA, FHL1, and RAMP3 genes were down-regulated in NSCLC while CEP55, PYCR1, and TPX2 genes were up-regulated. This evidence concerns the gene FHL1 and non-small cell lung carcinoma.